.svg)
Catalyze Dallas Appoints James Bendle as Partner
READ MORE
Catalyze Dallas has expanded the role of its Chief Financial Officer (CFO), James Bendle, to also include serving as a Partner for the company.
Catalyze Dallas Names William Cervin Principal
READ MORE
Catalyze Dallas has named William Cervin as Principal, a leadership role whereby he will serve interim CEO for new companies within the Catalyze portfolio.
Almaden Builds Business Operations to Catch up With Technology
READ MORE
Almaden Genomics building business operations to keep up with technological innovation
Almaden Names Ellen Gordon VP, Head of Business Development
READ MORE
Almaden Genomics has named Ellen Gordon as VP, Head of Business Development. She will help Almaden partner with clients to accelerate genomic research.
Almaden Genomics Names Board of Advisors
READ MORE
Almaden has announced its Board of Advisors, a highly regarded group of healthcare leaders with experience across a variety of industries.
OmicsEdge Partners with Almaden to Streamline Drug Discovery
READ MORE
A new drug discovery service from OmicsEdge using Almaden's g.nome™ makes it easy for labs to quickly analyze a patient’s medical condition and genomics.
BlueHalo and Alpine Partner for Break-Through Innovations in Unmanned Systems
READ MORE
BlueHalo Launches Next Generation of Lighter, Stronger, More Efficient Intense Eye UAS Featuring HX5® Injection Molded Chassis from Alpine Advanced Materials
Almaden Releases g.nome™ with Jupyter Notebook Integration
READ MORE
Almaden Genomics has updated its g.nome™ platform to integrate with Jupyter Notebook, which will further enable scientists to accelerate genomic discovery.
Almaden Genomics Names David Gascoigne as CEO
READ MORE
Gascoigne, a life sciences industry veteran, will drive Almaden as it accelerates genomic research and discovery.